期刊文献+

原发性肝癌患者CD_(105)、VEGF及TGF-β表达及临床意义 被引量:3

下载PDF
导出
摘要 目的探讨CD105、血管内皮细胞生长因子(VEGF)及转化生长因子-β(TGF-β)在原发性肝癌发生、发展中的作用。方法分别采用原位杂交法及ELISA法检测48例原发性肝癌患者肝组织CD105表达及血清VEGF、TGF-β表达水平。结果肝癌组织CD105表达明显高于正常肝组织,血清VEGF、TGF-β水平明显高于健康人,P均<0.05;有腹水转移者CD105表达及VEGF、TGF-β水平明显高于无腹水转移者(P<0.05)。结论 CD105、VEGF及TGF-β在原发性肝癌的发生、发展及腹水转移中起一定作用,可为原发性肝癌的生物治疗和预后判断提供依据。
出处 《山东医药》 CAS 北大核心 2011年第47期105-106,共2页 Shandong Medical Journal
  • 相关文献

参考文献4

  • 1Bodey BJ, Bodey B, Siegel SE, et al. Over-expression of endoglin ( CD105 ) : a marker of hear carcinoma-indued neovescularization [ J ]. Anticaneer Research, 1998,18 ( 8 ) :9621-3625.
  • 2Wikstrom P, Lissbrant LF, Statin P, et al. Endoglin( CD105 )is expressed on immature blood vessels and is mare for surrival in prostate cancer[ J]. Prostate, 2002,51 (5) :268-272.
  • 3Podar K, Anderson KC. The pathophysiologic role of VEGF in hema-tologic malignancies : therapeutic implications[ J]. Blood, 2005, 105 (4) : 1383-1395.
  • 4Langenskild M, Holmdahl L, Falk P. Increased TGF-1 protein expression in patients with advanced colorectal cancer[ J]. J Surg Oncol, 2008,97 (5) :409-415.

同被引文献48

  • 1李丙华,徐娅苹.CD_(105)标记微血管密度与喉癌临床病理特征相关性[J].中国耳鼻咽喉头颈外科,2004,11(6):343-345. 被引量:5
  • 2张萍,高媛.Cyclin D1在肿瘤中的表达及意义[J].山东医药,2005,45(34):69-70. 被引量:5
  • 3Ten Dijke P, Arthur HM. Extracellular control of TGF beta signa-ling in vascular development and disease [ J ]. Nat Rev Mol Cell Bi-ol,2007,8( 11) ;857 -869.
  • 4Sanchez - Eisner T,Botella LM, Velasco B,et al. Endo^in expres-sion is regulated by transcriptional cooperation between the hypoxiaand transforming growth factor - p pathways [ J ]. J Biol Chem,2002,277(46) :43799 -43808.
  • 5Davidson B,Stavnes HT,Forsund M,et al. CD105 ( Endoglin) ex-pression in breast carcinoma effusions is a marker of poor survival[J]. Breast,2010,19(6) :493 -498.
  • 6Conley BA’Smith JD,Guerrero - Esteo M,et al. Endoglin,a TGF -p receptor - associated protein, is expressed by smooth muscle cellsin human atherosclerotic plaques [ J ]. Atherosclerosis, 2000,153(2):323 -335.
  • 7Wheeler - Jones CP,Clarkin CE,Farrar CE,et al. Endoglin(CD 105 ) is not a specific selection marker for endothelial cellsin human islets of Langerhans [ J] . Diabetologia,2013,56(1):222 -224.
  • 8Hawinkels LJ,Kuiper P,Wiercinska E,et al. Matrix metalloprotein-ase - 14 ( MT1 - MMP) - mediated endoglin shedding inhibitstumor angiogenesis[ J]. Online First ,2010,70( 10) :4141 -4150.
  • 9Rubatt JM,Darcy KM,Hutson A,et al. Independent prognostic rel-evance of micro - vessel density in advanced epithelial ovariancancer and associations between CD31,CD105,p53 status,and an-giogenic marker expression: A Gynecologic Oncology Group study[J]. Gynecol Oncol,2009,112(3) :469 -474.
  • 10Davidson B, Stavnes HT. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival[ J]. Brest ,2010, 19(6) :493 -498.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部